skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Gemcitabine-Erlotinib Regimen (Code C63503)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Gemcitabine-Erlotinib Regimen

Definition: A regimen consisting of gemcitabine and erlotinib used for the treatment of pancreatic cancer.

NCI-GLOSS Definition: A chemotherapy combination used for the treatment of locally advanced and metastatic pancreatic cancer. It includes the drugs gemcitabine hydrochloride and erlotinib hydrochloride.

Label: Gemcitabine-Erlotinib Regimen

NCI Thesaurus Code: C63503 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1880941  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
gemcitabine-erlotinib regimen
Gemcitabine-Erlotinib Regimen
Gemcitabine-Tarceva Regimen
gemcitabine-Tarceva regimen

External Source Codes: 
PDQ Closed Trial Search ID 657337
PDQ Open Trial Search ID 657337 (check for NCI PDQ open clinical trial info)
UMLS CUI C1880941

Other Properties:
     Name Value (qualifiers indented underneath)
code C63503
DesignNote Source: NCCN Guidelines 2007
Legacy_Concept_Name Gemcitabine-Erlotinib_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom